Biological Networks and Pathways Study Guide

Administrative Announcements and Course Schedule

  • Midterm Grade Distribution:
    • The mean score for the midterm was 9292.
    • The median score for the midterm was 9494.
    • Several students achieved a perfect score of 100%100\%.
    • Students at the lower end of the distribution are encouraged to speak with the instructors regarding concerns.
  • Final Exam Details:
    • The final exam is not cumulative; it covers only four lectures and one discussion section delivered after the midterm.
    • Today's lecture on biological networks is the fourth and final lecture included in the exam material.
    • The proteomics student lectures are not included in the final exam content, as the process of preparing and delivering those lectures is considered a major separate effort.
    • The format of the final exam questions will be similar to the midterm.
  • Upcoming Schedule Overview:
    • Week 8, Monday: No lecture (time allocated for presentation preparation).
    • Week 8, Wednesday: No discussion section (time allocated for presentation preparation).
    • Week 8, Friday: Student Presentation Session 1.
    • Week 9, Monday: Holiday (No class).
    • Week 9, Wednesday & Friday: Continuation of student presentations.
    • Week 10, Monday & Wednesday: In-class review for the final exam and review in discussion sections.
    • Week 10, Friday: Final Exam.
  • Proteomics Presentation Requirements:
    • Slides and questions are due by Noon on May 21.
    • Each student must submit two questions per topic (22 questions for every topic assigned in the class, not just their own).
    • These questions are graded and form a portion of the proteomics grade.
    • Instructors will select from the submitted questions to ask during the Q&A portion of the presentations.

Introduction to Biological Systems and Networks

  • The Biological Hierarchy (Complexity Pyramid):
    • Level 1 (Individual Molecules): Atoms, genes, RNA, and proteins.
    • Level 2 (Functional Modules): Small regulatory motifs and functional units created by interacting parts.
    • Level 3 (Pathways): Larger functional structures composed of multiple modules.
    • Level 4 (Systems): Large-scale organization and systems-level networks.
  • The Importance of Interaction: Complexity in life is dictated by molecules interacting with each other rather than the molecules existing in isolation. Molecular systems biology focuses on understanding these connections.
  • Ubiquitous Network Types:
    • Evolutionary/Phylogenetic Networks: Tracing lineage and relationships over time.
    • Ecological Networks: Interactions between organisms in an environment.
    • Expression Networks: Inferred relationships based on gene expression patterns.
    • Regulatory Networks: Capture functional consequences (e.g., which genes regulate others) rather than just correlation.
    • Protein-Protein Interaction (PPI) Networks: Biophysical networks based on physical contact between proteins.
    • Metabolic Networks: Biochemical reactions occurring within a cell.

Experimental Identification: The Yeast Two-Hybrid (Y2H) Assay

  • Focus on Protein-Protein Interactions (PPI): Binding can result in recruitment of proteins to specific genomic loci, or induce conformational changes critical for protein function.
  • Basic Principle of Y2H:
    • Uses a reporter gene (e.g., GFP) whose expression is controlled by an upstream promoter.
    • Transcription factors are modular; the DNA Binding Domain (BD) and the Activation Domain (AD) can function when physically separated but brought into proximity.
  • The Components:
    • The Bait: A known protein of interest fused to the DNA Binding Domain (BD).
    • The Prey: A protein (often from a library) fused to the Activation Domain (AD).
  • The Mechanism:
    1. Both fusion proteins are expressed in a yeast cell.
    2. The BD of the bait binds to the promoter of the reporter gene.
    3. If the bait and prey interact physically, the AD is brought close enough to the promoter to initiate transcription of the reporter gene.
    4. Readouts: GFP (fluorescence) or survival factors (e.g., antibiotic resistance or nutritional markers).
  • Advantages:
    • In vivo method (occurs inside a living yeast cell).
    • Simple and elegant design.
    • High-throughput: Can be used to screen libraries of prey proteins against a single bait.
    • Capable of detecting transient interactions.
  • Limitations:
    • Chimeras: Fusing domains to proteins may cause conformational changes that alter or inhibit natural function.
    • Environment: Yeast cells do not always provide the correct context for human protein interactions (e.g., post-translational modifications or localization).
    • Localization issues: Proteins that never meet in a human cell (e.g., one nuclear, one cytoplasmic) might show an interaction in Y2H that is not biologically relevant in vivo.
    • Binary constraint: It typically only detects interactions between two proteins; it cannot easily identify interactions that require a large protein complex to be stable.

Technical Network Terminology and Properties

  • Nodes and Edges:
    • Nodes: Represent biological units (proteins, genes, metabolites).
    • Edges: Represent relationships (physical interaction, regulation, co-expression).
  • Types of Edges:
    • Directed: Arrows represent activation (→\rightarrow); flat bars represent inhibition (⊣\dashv).
    • Undirected: Simply represent a connection without specified direction.
  • Node Degree (Connectivity, kk):
    • Defined as the number of links a node has to other nodes.
    • Undirected Networks: Count all connected edges.
    • Directed Networks:
      • Incoming Degree (KinK_{in}): Number of edges pointing into the node.
      • Outgoing Degree (KoutK_{out}): Number of edges pointing away from the node.
  • Degree Distribution (P(k)P(k)):
    • The probability that a randomly selected node has exactly kk links.
    • Observed Degree Distribution: Calculated by counting the number of nodes with kk links (n(k)n(k)) and dividing by the total number of nodes (NtotalN_{total}).
    • P(k)=N(k)NtotalP(k) = \frac{N(k)}{N_{total}}.

Scale-Free Networks and the Power Law

  • Power Law Definition: Biological networks are described as "Scale-Free" because their degree distribution follows a power law asymptotically.
    • Equation: P(k)≈k−γP(k) \approx k^{-\gamma}, where γ\gamma (gamma) is a constant parameter specific to the network.
  • Log-Log Characterization: Taking the logarithm of both sides results in a linear relationship: log⁡(P(k))=−γlog⁡(k)\log(P(k)) = -\gamma \log(k).
    • This results in a straight line with a negative slope on a log-log plot.
  • Implication: The probability of finding a node with a very high degree (a "hub") decreases exponentially as kk increases. Highly connected nodes (hubs) are rare, while nodes with few connections are very common.
  • Examples of Scale-Free Networks:
    • Movie actor collaboration networks.
    • The Internet (links between web pages).
    • Power grids.
    • Protein interaction networks (e.g., the yeast proteome map).

Network Robustness and the "Small World" Phenomenon

  • Small World Property: Any two nodes in a biological network can typically be connected by a path of only a few links (often 33 to 55 hops).
    • This means local perturbations (e.g., changes in one metabolite concentration) can spread through the entire network efficiently.
  • Robustness: The ability of a system to maintain function despite errors or failures.
    • Resilience to Random Failure: Because most nodes are not hubs, random mutations or failures likely hit low-connectivity nodes, leaving the overall network structure intact.
    • Sensitivity to Targeted Attacks: Because hubs are the "glue" of the network, targeted disruption of a hub is lethal and can pull the entire network apart.
  • Medical Application: Drug development often targets hub genes in cancer-related networks to effectively kill malignant cells, though this can lead to side effects due to the hub's many connections.

Pathways and Enrichment Analysis

  • Distinction Between Networks and Pathways:
    • All pathways are networks, but not all networks are pathways.
    • Pathways: A subset of a network with a specific functional label, biological process, or phenotypic outcome.
    • Modules: Interacting molecules that fulfill a specific unit of function.
  • Pathway Overlap and Enrichment Analysis:
    • Used to determine if a set of differentially expressed genes (DEGs) is significantly associated with a known pathway.
    • Expected Overlap Calculation:
      • Expected Overlap=(Size of DEG List×Size of Pathway)Total Number of Background Genes\text{Expected Overlap} = \frac{(\text{Size of DEG List} \times \text{Size of Pathway})}{\text{Total Number of Background Genes}}
      • Example: If your list has 200200 genes, the pathway has 100100, and the genome (background) has 20,00020,000, the expected overlap by chance is 200×10020,000=1\frac{200 \times 100}{20,000} = 1.
      • If your observed overlap is 88, this is significantly higher than the expected 11.
  • KEGG (Kyoto Encyclopedia of Genes and Genomes):
    • A major public database used to study pathways.
    • Allows users to search by gene to see involved pathways or compare pathways across species.

Questions & Discussion

  • Q: Regarding references for the presentation, is there a limit or requirement?
  • A: There is no specific limit; use as many as you actually utilized for your research.
  • Q: Is Yeast Two-Hybrid (Y2H) a good technique to use for extracellular proteins?
  • A: No. Extracellular proteins are secreted outside the cell, meaning they likely won't reach sufficient abundance within the yeast cell environment to show interaction readouts.
  • Q: If I discover a novel gene using RNA-Seq and predict an Open Reading Frame (ORF), can I use Y2H even if it's never been studied?
  • A: Yes. You can clone the ORF into a plasmid, create a fusion protein, and test it in yeast without knowing its function or structure beforehand.
  • Q: To make the fusion protein, do we need to know the structure of the protein?
  • A: No, you only need the sequence of the Open Reading Frame. You can attach the fusion domain to either the N-terminal or C-terminal, though you must be careful as this can sometimes affect the protein's native folding.